Renalytix Total Stockholder Equity from 2010 to 2024
| RNLX Stock | USD 0.45 0.02 4.65% |
Total Stockholder Equity | First Reported 2010-12-31 | Previous Quarter 21.2 M | Current Value 40.5 M | Quarterly Volatility 26.9 M |
Check Renalytix financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Renalytix's main balance sheet or income statement drivers, such as Interest Expense of 4 K, Other Operating Expenses of 29.1 M or Tax Provision of 2.4 K, as well as many indicators such as Price To Sales Ratio of 38.53, Dividend Yield of 0.0 or PTB Ratio of 9.12. Renalytix financial statements analysis is a perfect complement when working with Renalytix Valuation or Volatility modules.
Renalytix | Total Stockholder Equity |
Latest Renalytix's Total Stockholder Equity Growth Pattern
Below is the plot of the Total Stockholder Equity of Renalytix AI over the last few years. It is the total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders. Renalytix's Total Stockholder Equity historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Renalytix's overall financial position and show how it may be relating to other accounts over time.
| Total Stockholder Equity | 10 Years Trend |
|
Total Stockholder Equity |
| Timeline |
Renalytix Total Stockholder Equity Regression Statistics
| Arithmetic Mean | 18,832,611 | |
| Geometric Mean | 436,523 | |
| Coefficient Of Variation | 142.66 | |
| Mean Deviation | 20,148,615 | |
| Median | (9,389) | |
| Standard Deviation | 26,865,818 | |
| Sample Variance | 721.8T | |
| Range | 95.1M | |
| R-Value | 0.63 | |
| Mean Square Error | 467.8T | |
| R-Squared | 0.40 | |
| Significance | 0.01 | |
| Slope | 3,790,556 | |
| Total Sum of Squares | 10104.8T |
Renalytix Total Stockholder Equity History
About Renalytix Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Renalytix income statement, its balance sheet, and the statement of cash flows. Renalytix investors use historical funamental indicators, such as Renalytix's Total Stockholder Equity, to determine how well the company is positioned to perform in the future. Although Renalytix investors may use each financial statement separately, they are all related. The changes in Renalytix's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Renalytix's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Renalytix Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Renalytix. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Total Stockholder Equity | 21.2 M | 40.5 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Renalytix Stock Analysis
When running Renalytix's price analysis, check to measure Renalytix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Renalytix is operating at the current time. Most of Renalytix's value examination focuses on studying past and present price action to predict the probability of Renalytix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Renalytix's price. Additionally, you may evaluate how the addition of Renalytix to your portfolios can decrease your overall portfolio volatility.